Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Aldeyra Therapeutics (ALDX) Announces Proposed 5.25M Share Public Offering of Common Stock
-
Veru Announces Proposed Public Offering of Common Stock
-
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
-
HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
-
PolarityTE (PTE) Form 483 Observations 'Likely Minor' - Cantor Fitzgerald
-
Aldeyra Therapeutics (ALDX) PT Raised to 'Street High' $30 at Cantor Fitzgerald
-
PDL BioPharma to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
/C O R R E C T I O N -- Infinity Pharmaceuticals, Inc./
-
Infinity To Present At Cantor Fitzgerald Global Healthcare Conference
-
ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Cerus to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Amarin (AMRN) Has Solid IP on Vascepa Despite Questions - Cantor Fitzgerald
-
Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Intra-Cellular Therapies to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2018
-
Tarveda Therapeutics to Present at Cantor Fitzgerald 2018 Global Healthcare Conference
-
Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts Evofem Biosciences Inc (EVFM) at Overweight
-
Ocugen to Present at Two Upcoming Investor Conferences
-
Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference
-
CTI BioPharma to Present at the Cantor Fitzgerald Global Healthcare Conference Wednesday, Oct. 3
-
Anavex Life Sciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Fennec to Present at Cantor Fitzgerald Global Healthcare Conference on October 1, 2018 in New York City
-
Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Aduro Biotech to Present at Two Investor Conferences in October
-
BioCryst Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Corvus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Iterum to Present at Cantor Fitzgerald Global Healthcare Conference
-
Exelixis to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018
-
Iterum to Present at Cantor Fitzgerald Global Healthcare Conference
-
AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October
-
Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference
-
Aptinyx to Present at Cantor Fitzgerald Global Healthcare Conference
-
Aptinyx to Present at Cantor Fitzgerald Global Healthcare Conference
-
Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ur-Energy Inc. Announces Closing of $10.0 Million Public Equity Offering
-
Opnet Technologies, Inc. (OPNT) Prices Offering of ~706K Shares at $17
-
Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
CRH Medical Corporation To Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Melinta Therapeutics to Present at Upcoming Investor Conferences
-
Selecta Biosciences to Present at the Cantor Fitzgerald Global Healthcare Conference on October 02, 2018
-
Pieris Pharmaceuticals to Present at Investor Conferences in October
-
DURECT to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Catalyst Biosciences to Present at Two Upcoming Healthcare Investor Conferences


